XXXX at Westmead Hospital from 1979-1985.

@entity1 @entity5 @entity189
The aim of this study was to evaluate the various treatment options, including radiotherapy, surgery and chemotherapy, when all @entity1 with @entity189 were assessed and managed by the same team. From December 1, 1979 to December 31, 1985, 144 @entity1 with @entity189 were referred to Westmead Hospital. Eighty-five @entity1 were @entity1 , 59 @entity1 were @entity1 and the median age was 63 years. Twenty-five @entity1 were at stage I, 75 @entity1 were at stage II, 24 @entity1 were at stage III and 20 @entity1 were at stage IV of @entity5 . Forty-two @entity1 underwent surgical resection. Fifty @entity1 underwent radical radiotherapy, 30 @entity1 underwent palliative radiotherapy and 22 @entity1 underwent palliative intubation. The operative mortality of those @entity1 who underwent surgery was zero. The treatment mortality of those who underwent radical radiotherapy was 6%, and for those who underwent palliative radiotherapy, was 16.7%. The mortality after intubation was 12.5%. The prevalence of benign strictures was 7.5% after surgery, 33% after radical radiotherapy and 8% after palliative radiotherapy. The prevalence of @entity5 (recurrent disease) was 2.5% after surgery, 21% after radical radiotherapy and 20% after palliative radiotherapy. The median survival after surgery was 12 months; that after radical radiotherapy, 12 months; that after palliative radiotherapy, six months; and that after intubation, 3.5 months. Where all @entity1 with @entity189 were managed by a team approach the treatment mortality was low but the long-term survival remained poor.
